ORION PHARMA A/S: Financial statements 2013
CVR: 20601116
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
ORION PHARMA A/S (CVR 20601116) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 164,778,384 and a net result of DKK 25,585,348. The profit margin was 15.5%. Equity in the 2013 report amounted to DKK 39,117,196. The solvency ratio was 54.1%. The company had 33 employees in the financial year.
- Revenue
- DKK 164,778,384
- Gross Profit
- DKK 64,881,666
- Profit/Loss
- DKK 25,585,348
- Equity
- DKK 39,117,196
- Total Assets
- DKK 72,362,870
- Employees
- 33
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
ORION PHARMA A/S has published its annual report for 2012.
About ORION PHARMA A/S
ORION PHARMA A/S is a Danish company of the type Aktieselskab based in København S, founded in 1953. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ERCOPHARM A/S. The management consists of Jesper Otto Qvist-Pedersen. The board consists of Satu Maarit Ahomäki (chair), Mikko Tapani Kemppainen and René Kristian Lindell. The company is owned by Orion Corporation. The company has 14 employees (2026). In 2025, the company reported revenue of DKK 329,561,856 and a net result of DKK 10,525,947 compared with DKK 10,899,639 the year before. Equity in the 2025 report amounted to DKK 32,510,625.